SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?


To: Germanecki who wrote (962)11/25/2008 10:09:12 AM
From: ghmm  Respond to of 965
 
Are you sure this is the Morphosys compound? I couldn't find any mention on the Morphosys site other then P1 undisclosed indication. If you have a link I would appreciate it to add to my list of IPF compounds.

I had seen J&J collaborated with Five Prime a while ago they also have an oncology product that may be being tried in IPF.
fiveprime.com

I am not a science guy but an MAB for IPF seems to be something pretty ambitious considering what is known about the disease today.

Thanks in advance.